9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid

**Description:** 9-Benzyl-2-,3-,4-,5-,6-,7-,8-, or -tetrahydronaphtho[2',1':5',6']indolo[7a-a]carbazoles are a class of carbazole derivatives. The specific compound "9-benzyl--tetrahydronaphtho[2',1':5',6']indolo[7a-a]carbazoles" is not widely described in the literature as a marketed drug. However structurally similar compounds have been studied for their potential as selective inhibitors of adipocyte fatty-acid binding protein (A-FABP). This compound is classified as an experimental small molecule and has not been approved for any indication by regulatory agencies such as the FDA or EMA. It is primarily used in research settings to investigate its biological activity and mechanism of action. **Mechanism of Action:** The compound acts as a selective inhibitor of adipocyte fatty-acid binding protein (A-FABP), which plays a role in lipid transport and metabolism within adipocytes. Inhibition of A-FABP may have implications for metabolic diseases such as obesity and atherosclerosis[6].

Other names

9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid1H-Carbazole-8-carboxylic acid, 2,3,4,9-tetrahydro-9-(phenylmethyl)-[ACD/Index Name]9-Benzyl-2,3,4,9-tetrahydro-1H-carbazol-8-carbonsäure (German)Acide 9-benzyl-2,3,4,9-tétrahydro-1H-carbazole-8-carboxylique (French)9-benzyltetrahydrocarbazolone